Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Aarey Drugs & Pharmaceuticals
Start SIPAarey Drugs & Pharmaceuticals F&O
Aarey Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Aarey Drugs & Pharms. has an operating revenue of Rs. 376.32 Cr. on a trailing 12-month basis. An annual revenue growth of 39% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 62 | 76 | 117 | 120 |
| Operating Expenses Qtr Cr | 61 | 72 | 118 | 118 |
| Operating Profit Qtr Cr | 2 | 4 | -1 | 2 |
| Depreciation Qtr Cr | 1 | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 0 | 0 | 0 | 2 |
| Net Profit Qtr Cr | 0 | 3 | 1 | 0 |
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 27.02
- 50 Day
- 30.33
- 100 Day
- 33.11
- 200 Day
- 35.4
- 20 Day
- 27.13
- 50 Day
- 31.26
- 100 Day
- 34.72
- 200 Day
- 35.69
Aarey Drugs & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 25.29 |
| Second Resistance | 26.22 |
| Third Resistance | 26.74 |
| RSI | 26.17 |
| MFI | 22.73 |
| MACD Single Line | -1.8 |
| MACD | -1.98 |
| Support | |
|---|---|
| First Resistance | 23.84 |
| Second Resistance | 23.32 |
| Third Resistance | 22.39 |
Aarey Drugs & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 72,630 | 4,478,366 | 61.66 |
| Week | 86,229 | 5,140,985 | 59.62 |
| 1 Month | 47,036 | 2,788,274 | 59.28 |
| 6 Month | 62,285 | 3,455,583 | 55.48 |
Aarey Drugs & Pharmaceuticals Result Highlights
Aarey Drugs & Pharmaceuticals Synopsis
NSE-Medical-Diversified
Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 492.68 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2022. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.| Market Cap | 60 |
| Sales | 376 |
| Shares in Float | 1.27 |
| No of funds | 2 |
| Yield | 0.44 |
| Book Value | 0.52 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | |
| Alpha | -0.14 |
| Beta | 0.96 |
Aarey Drugs & Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 50.03% | 50.03% | 50.03% | |
| Foreign Portfolio Investors | 3.92% | 3.98% | 3.92% | |
| Individual Investors | 42.41% | 42.25% | 42.48% | |
| Others | 3.64% | 3.74% | 3.57% |
Aarey Drugs & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Mihir R Ghatalia | Chairman & Managing Director |
| Mr. Nimit Rajesh Ghatalia | Executive Director |
| Ms. Archana Pramod Wani | Woman Director |
| Mr. Lalit Radhakrishna Tulsiani | Independent Director |
| Mr. Anil Mandal | Independent Director |
| Mr. Chetan K Mehta | Independent Director |
Aarey Drugs & Pharmaceuticals Forecast
Price Estimates
Aarey Drugs & Pharmaceuticals FAQs
What is Share Price of Aarey Drugs & Pharmaceuticals ?
Aarey Drugs & Pharmaceuticals share price is ₹23 As on 26 March, 2023 | 16:53
What is the Market Cap of Aarey Drugs & Pharmaceuticals ?
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹59.5 Cr As on 26 March, 2023 | 16:53
What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?
The P/E ratio of Aarey Drugs & Pharmaceuticals is 14.7 As on 26 March, 2023 | 16:53
What is the PB ratio of Aarey Drugs & Pharmaceuticals ?
The PB ratio of Aarey Drugs & Pharmaceuticals is 0.5 As on 26 March, 2023 | 16:53